s6y
Company name or ticker
Search
Ernexa Therapeutics Inc.
424B5
Prospectus filed pursuant to Rule 424(b)(5)
Filed
Tuesday, February 10, 2026
Accession number
0001493152-26-005898
Documents
424B5
424B5
On sec.gov
Filing index
All files
Complete submission text
SGML header